B7 homolog 6 promotes the progression of cervical cancer

xlomafota13 shared this article with you from Inoreader B7 homolog 6 promotes the progression of cervical cancer Via Experimental and therapeutic medicine Exp Ther Med. 2021 Jul;22(1):774. doi: 10.3892/etm.2021.10206. Epub 2021 May 18. ABSTRACT B7 homolog 6 (B7-H6) was recently discovered to act as a co-stimulatory molecule. In particular, the expression of B7-H6 has been found to play an important biological role in several types of tumors. The aim of the present study was to determine the role of B7-H6 in cervical cancer. Immunohistochemistry was used to analyze the expression levels of B7-H6 in cervical precancerous and cancerous tissues. Furthermore, the expression of B7-H6 was knocked down in HeLa cells using short hairpin RNA and the effects of B7-H6 on HeLa cell proliferation, migration and invasion were determined using Cell Counting Kit-8, colony formation, wound healing and Transwell invasion assays, respectively. In addition, flow cytometry was used to analyze the levels of cell apoptosis and the cell cycle distribution. The results of the immunohistochemical staining revealed that the expression levels of B7-H6 were upregulated in cervical lesions. Furthermore, the expression levels of B7-H6 were positively associated with the clinical stage of the cervical lesions. B7-H6 knockdown suppressed the invasive, migratory and proliferative abilities of HeLa cells, and promoted G1 cell cycle arrest and apoptosis. In conclusion, the findings of the present study suggested that B7-H6 may serve as a novel oncogene and may hold promise as a potential therapeutic target for cervical cancer. PMID:34055073 | PMC:PMC8145428 | DOI:10.3892/etm.2021.10206 View on the web Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.